DiagnosticON’s Market Research Journey with GIST in the United States
At DiagnosticON, we believe that a great healthcare solution starts with truly understanding the needs of the people it...
Read MoreWelcome to DiagnosticON
We are proud to introduce DiagnosticON, an advanced, AI-driven risk evaluation system designed to automate and enhance the detection of serious short-term complications following acute myocardial infarction and heart failure.
By leveraging patient characteristics, clinical data, and validated predictive models, DiagnosticON provides a comprehensive solution to improve patient outcomes, support timely medical decision-making, and reduce preventable hospital readmissions.
The largest hospital systems globally, including those in the US, UK, and Germany, are implementing programs to link payment to the quality of hospital care. This includes penalizing hospitals when patients with acute myocardial infarction and heart failure experience unplanned readmission due to complications within 30 days after hospital discharge. Despite these efforts, many of patients are still being readmitted to the hospital within 30 days after discharge.
We aim to support hospitals in the U.S. and Europe in achieving an optimal balance — delivering the best possible patient outcomes while minimizing unnecessary costs, avoiding penalties, and strengthening value-based healthcare performance.
Compared to traditional physician judgment during discharge planning, DiagnosticON offers:
Enhanced Risk Assessment Accuracy: Providing individualized, evidence-based risk predictions for 30-day readmission and survival, grounded in validated clinical models and real-time patient data.
Top Risk Factor Identification: Automatically identifying and ranking the most influential clinical and care-related factors contributing to each patient's risk, helping clinicians target modifiable issues.
Integrated Cost-Effectiveness Analysis: Evaluating the financial trade-offs between early discharge versus extended hospitalization, supporting both patient outcomes and hospital budget optimization.
Dynamic Scenario Simulation: Allowing clinicians to model "what-if" changes to key risk factors and instantly visualize the impact on patient outcomes and hospital resource use.
Streamlined Decision Support: Accelerating complex discharge decision-making with intuitive dashboards, structured shared-decision tools, and guideline-based recommendations — all seamlessly integrated with hospital EHR systems via Redox Nexus.
Through these capabilities, DiagnosticON helps hospitals improve patient care, reduce avoidable readmissions, and drive operational and financial efficiency.
Discover MoreWe are proud to offer three advanced clinical features and two integrated solutions, each available in two formats: either as a standalone web-based calculator or as a combined web calculator and fully automated, EHR-integrated system.
DiagnosticON HF Risk Evaluation delivers real-time, individualized predictions of 30-day readmission risk and clinical outcomes, using validated models and patient-specific data.
DiagnosticON Scenario Analysis empowers clinicians to explore "what-if" scenarios by adjusting patient and care variables, instantly visualizing their impact on risk, cost-effectiveness, and outcomes.
DiagnosticON Cost-Effectiveness & Decision Aid transforms clinical risk evaluation into clear, actionable insights on financial and health outcome trade-offs.
The DiagnosticON Platform combines advanced clinical features for risk evaluation, scenario analysis, cost-effectiveness modeling, and shared decision-making, utilizing patient characteristics and care data to optimize hospital discharge planning and reduce readmissions.
Currently, nearly 6.5 million Americans over the age of 20 are living with heart failure. This figure is expected to increase to 8.5 million by 2030. An estimated 960,000 new heart failure cases are reported annually. Heart failure is responsible for about 8.5% of all heart disease-related deaths in the United States. In 2018, heart failure was mentioned in 379,800 death certificates, accounting for 13.4% of all deaths. Heart failure remains the leading cause of hospitalizations among the Medicare population. Consequently, Medicare has started implementing programs that tie payment to the quality of hospital care. This includes penalties for hospitals if patients with heart failure experience unplanned readmissions due to complications within 30 days after hospital discharge (Medicare Hospital Readmissions Reduction Program).
Watch MoreAs a dynamic AI startup, we are committed to keeping you connected with the cutting-edge advancements we're making in the field. Here, we'll share our latest news, industry insights, product launches, and significant milestones. Dive in to discover how we're shaping the future of technology and driving change in the industry.
At DiagnosticON, we believe that a great healthcare solution starts with truly understanding the needs of the people it...
Read MoreCompany Announcement Today, we are excited to share another major milestone in DiagnosticON’s journey toward transforming hospital care.DiagnosticON has...
Read MoreCompany Announcement Today, we are thrilled to announce that DiagnosticON has reached yet another remarkable landmark in its journey...
Read MoreThe best way to predict the future is to invent it.
Alan Kay
Computer ScientistMedicine is a science of uncertainty and an art of probability.
It is far better to foresee even without certainty than not to foresee at all.
As a forward-thinking startup focused on leveraging Artificial Intelligence for healthcare, we are always seeking strategic alliances that can enhance our mission to revolutionize patient care. Whether you're a tech firm, healthcare provider, or research institution, there's room to collaborate and make a significant impact in the health landscape.
We are deeply committed to forging strong alliances with academic institutions as part of our innovation journey.
At DiagnosticON, we firmly believe in the power of collaboration and are keen on fostering strong partnerships with healthcare institutions worldwide.
DiagnosticON Seeks Collaborative Opportunities with MedTech and Pharma Industries
Pre-register now for early access to DiagnosticON